The number of monthly permits increased again as the generic release of AstraZeneca's diabetes combination drug "Xigduo XR (Metformin+Dapagliflozin Propanediol Hydrate)" first appeared in October.

As many as 31 generics for Xigduo XR were approved in October, all of which are consignment items manufactured by Richwood Trading Company. It is interpreted that the number of consigned items was large because the consignment manufacturer applied for permission before the enforcement of the Bioequivalence Restriction Act (a law that can only be consigned to three companies by restricting the sharing of BA test data) enforced in July.

According to the MFDS on the 31st, there were 62 OTCs and 11